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Abstract
Ms1 (also known as STARS and ABRA) has been shown to act as an early stress response
gene in processes as different as hypertrophy in skeletal and cardiac muscle and growth of
collateral blood vessels. It is important for cardiac development in zebrafish and is upregu-
lated in mouse models for cardiac hypertrophy as well as in human failing hearts. Ms1 pos-
sesses actin binding sites at its C-terminus and is usually found in the cell bound to actin
filaments in the cytosol or in sarcomeres. We determined the NMR structure of the only
folded domain of Ms1 comprising the second actin binding site called actin binding domain
2 (ABD2, residues 294–375), and found that it is similar to the winged helix-turn-helix fold
adopted mainly by DNA binding domains of transcriptional factors. In vitro experiments
show specific binding of this domain, in combination with a newly discovered AT-hook motif
located N-terminally, to the sequence (A/C/G)AAA(C/A). NMR and fluorescence titration
experiments confirm that this motif is indeed bound specifically by the recognition helix. In
neonatal rat cardiomyocytes endogenous Ms1 is found in the nucleus in a spotted pattern,
reminiscent of PML bodies. In adult rat cardiomyocytes Ms1 is exclusively found in the sar-
comere. A nuclear localisation site in the N-terminus of the protein is required for nuclear
localisation. This suggests that Ms1 has the potential to act directly in the nucleus through
specific interaction with DNA in development and potentially as a response to stress in adult
tissues.
PLOS ONE | DOI:10.1371/journal.pone.0144614 December 14, 2015 1 / 18
OPEN ACCESS
Citation: Zaleska M, Fogl C, Kho AL, Ababou A,
Ehler E, Pfuhl M (2015) The Cardiac Stress
Response Factor Ms1 Can Bind to DNA and Has a
Function in the Nucleus. PLoS ONE 10(12):
e0144614. doi:10.1371/journal.pone.0144614
Editor: Fenfei Leng, Florida International University
Bimolecular Sciences Institute, UNITED STATES
Received: October 16, 2015
Accepted: November 21, 2015
Published: December 14, 2015
Copyright: © 2015 Zaleska et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: The structure of ABD2
is available from the Protein Data Bank with ID 2KRH
(10.2210/pdb2krh/pdb). All other data are available in
the manuscript or the Supporting Information.
Funding: This work was supported by a
Departmental BBSRC studentship to Claudia Fogl,
administered by the then Department of Biochemistry,
University of Leicester, no grant number (http://www.
bbsrc.ac.uk). It was also supported by the BHF
Centre of Excellence at KCL, studentship
programme, PhD studentship to Mariola Zaleska via
Mark Pfuhl, no grant number (https://www.bhf.org.uk).
Introduction
Ms1/STARS is a stress response protein of the cardiac and skeletal muscle (recently reviewed
in [1]). It was discovered as a protein overexpressed in cardiomyocytes early in the hyperten-
sion model of rat aortic banding [2] and as a novel gene expressed exclusively in the mouse
heart tube [3]. It was shown to be important for the maintenance of cardiac development in
zebrafish [4] and is upregulated in mouse models of cardiac hypertrophy and in failing human
hearts [5]. Its expression appears to be regulated by MEF-2, a myogenic transcription factor
also involved in stress response signalling [5] as well as GATA4 [6]. Overexpression of Ms1 in
cardiomyocytes sensitises the heart to pressure overload and calcineurin signalling, leading to
an exaggerated deterioration of cardiac function. In H9c2 cells, overexpression of Ms1 induces
cellular hypertrophy and protects against apoptosis through alteration of the expression pat-
tern of genes regulated by the MRTF/SRF pathway [7]. Ms1 is a highly conserved protein pres-
ent in all eukaryotes and in vertebrates is expressed mainly in cardiac and skeletal muscle.
Recently, it was also found in endothelial tissue involved in the formation of collateral blood
vessels [8].
The size of the protein increased in the course of evolution from a short, 81 residue version
called COSTARS [9] in the smallest known eukaryotes via a version of about 150 residues in
insects and nematodes and just under 400 amino acids in vertebrates [10] (S1 Fig). The protein
was shown to bind to F-actin [3,10], which was increased by its interaction with ABLIM-1/2
[11]. We were able to show that only its highly conserved C-terminus assumes a well-folded
structure, while the rest of the protein is highly flexible and unfolded [10]. The folded C-termi-
nal domain, termed ABD2 (actin binding domain 2, residues 294–375), contains one of two
independent F-actin binding sites, immediately preceded by a second one, termed ABD1
(residues 193–295), of higher affinity [10]. Ms1 is assumed to cooperate with Rho and other
upstream factors in stabilising cellular F-actin. Stabilising F-actin leads to a reduction in the
free G-actin pool and consequently the release of the myocardin-regulated SRF cofactors
MRTF-A and -B for translocation to the nucleus where they can influence transcriptional regu-
lation [3,5]. In summary, Ms1/STARS has somewhat contrasting functions: on the one hand, it
has an essential function in cardiogenesis and is even cardioprotective. On the other hand, its
overexpression renders cardiomyocytes susceptible to pressure overload and heart failure. The
current view is that Ms1 acts as an indirect regulator of transcription by controlling the nuclear
translocation of MRTFs via F-actin polymerisation.
Here, we determined the structure of its only folded domain, ABD2, to better understand its
actin binding mechanism. As in the case of the homologous protein COSTARS [12], we found
that it has a winged helix-turn-helix fold, most commonly found in the DNA binding domain
of transcription factors. We were able to show that an extended construct of ABD2, including
an AT-hook DNA binding motif, is indeed able to bind to DNA in a sequence specific manner.
Cell biology studies show that the protein is able to reach the nucleus based on NLS dependent
transport in a tightly regulated fashion. This suggests that in addition to the established func-
tion via a rho/actin/MRTF/SRF pathway Ms1 can also act directly in the nucleus.
Materials and Methods
All animals used in this study received humane care under the guidelines of the Animals (Sci-
entific Procedures) Act, 1986
Sequence analysis
The alignment for full length Ms1 was based on 3 cycles ofC-Blast alignments using the
default parameters of the EBI web server (www.ebi.ac.uk) and a cutoff value of 2 10−20. After
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each cycle sequence hits were inspected manually and only complete proteins were carried
over to the next cycle while proteins characterised as fragments were removed to avoid false
identification of shorter Ms1 versions. Also sequences, which were significantly longer
(>450aa) or had a distinctly different description were removed. A representative subset of
sequences was extracted, aligned using the default settings of clustalw and coloured with clus-
talx as described previously [13]
Experimentally validated phosphorylation sites were searched on the RegPhos [14] and
PhosphoSitePlus [15] web servers. Nuclear localisation sequences (NLS) were searched with
PredictNLS [16].
Protein preparation
ABD2 (residues 294–375) and extended ABD2 (residues 270; 281 and 287–375) as well as N-
terminus (residues 1–99) and ABD1 (residues 193–295) from rat Ms1 were cloned into
pLEICS-07 vector, which contains an N-terminal, TEV cleavable, poly-histidine tag (kindly
provided by Dr. Xiaowen Yang, PROTEX, University of Leicester). They were expressed in E.
coli strain BL21 (Invitrogen) and purified as described previously [10]. The protein was dia-
lysed into appropriate buffer (NMR, EMSA or SELEX buffer, see below) and concentrated
using a viva-spin 20 concentrator with a MES membrane and a 3kD molecular weight cutoff.
NMR spectroscopy & structure determination
All experiments were performed at 298 K and pH 7.2 with a range of concentrations between
188 μM and 500 μM in a buffer consisting of 20mM sodium phosphate pH 7.0, 50mM NaCl,
2mM DTT, 0.02% NaN3, on Bruker Avance spectrometers at 500, 600, 700 and 800 MHz all
equipped with cryoprobes. Further details of the individual experiments used can be found in
PDB entry 2KRH.
CCPN Analysis [17] was used to analyse the spectra, pick the peaks, perform the sequence
specific assignment and to extract distance constraints for structure calculation.
Dihedral angle constraints were extracted from chemical shifts with TALOS [18]. They
were combined with NOE distance restraints and used in CYANA 2.1 [19] to calculate the
structure of ABD2 using default settings and the NOA protocol to assign ambiguous NOEs.
The NMR constraints and statistics of the structure calculation are summarised in Table 1. Fur-
ther details of the individual experiments used to collect constraints used in the structure calcu-
lation can be found in PDB entry 2KRH. Structure similarities were analysed with the DALI
server [20,21].
Table 1. Structure calculation statistics of ABD2.
Input Constraints
Dihedral Angle Constraints 130
NOE-derived Distances 1679
Hydrogen Bond Constraints 32
Structure Statistics
Backbone RMSD 0.54 Å
Heavy atom RMSD 1.30 Å
Residues in core region of the Ramachandran plot 83.3%
Residues in allowed region of the Ramachandran plot 16.4%
Average / maximal violation of NOE constraints 0.0222 / 0.135
Average / maximal violation of dihedral constraints 0.3669 / 0.4822
doi:10.1371/journal.pone.0144614.t001
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DNA binding assays & SELEX
Protein in EMSA buffer (20 mM PO4, 100 mMNaCl, 0.01% Triton X-100, pH 7.5) was incu-
bated with 1 μM or 2 μM of DNA in a total volume of 20 μl. Protein concentration ranged
from 1 μM to 100 μM depending on the experiment. FOXO3a, an extensively characterised
transcription factor was used as a positive control [22]. As a DNA probe, a random dsDNA
library (Gene Link) or ds oligonucleotides (Biomers) were used. The dsDNA library was pre-
pared as previously described [23], whilst ds oligonucleotides were prepared by mixing equal
molar amounts of single stranded complementary oligonucleotide and heating for 10 minutes
at 95°C, followed by a gradual cooling to room temperature in a thermocycler for 5 hours.
The EMSA samples were incubated for 30 minutes at room temperature and then 2 μl of 80%
glycerol was added and the samples were loaded onto a 1.6% agarose gel prepared with SYBR-
Safe stain (Invitrogen). The gel was run for 40 minutes at 80V and the samples were visualised
under UV light.
To identify sequences bound by ABD2 or the extended construct, a SELEX experiment was
performed as previously described [23], except that a shorter library was used (containing N18
in the random region) and that the final pool was cloned into pCR 2.1 vector using the TA
cloning kit (Invitrogen). To identify the positive clones, colony PCR was performed and the
positive PCR products were sequenced (Beckman Coulter Genomics). The sequencing data
was further analysed using the MEME suite [24] (http://meme.nbcr.net)
Antibody production
To generate antibodies against Ms1, 3 different Ms1 constructs were prepared: N-terminus (1–
99 aa), ABD1 (193–295 aa) and ABD2 (294–375 aa). They were expressed and purified as
described earlier [10]. 10 mg/ml of each protein was sent for rabbit immunisation to 2 different
companies (Absea, China and Bioscience, Germany). The obtained sera were tested using
Western blot and immunofluorescence. The serum that gave the best results (aABD2chn) was
further validated using overexpression studies and immunofluorescence. As a control for speci-
ficity the antibody was pre absorbed with the immunising antigen and then used on western
blots and in immunofluorescence. No signal was detected in both with pre absorbed antibody
(aABD2chn antibody validation–S4 and S5 Figs).
Transfection constructs and point mutation
Myc-tagged mouse Ms1 cloned into the mammalian expression vector pcDNA3.1(+) was
kindly provided by Dr. A. Koekemoer, University of Leicester. Point mutations were created
using the QuikChange Site Directed Mutagenesis kit (Agilent Technologies). Primers carrying
the desired mutation were designed using the QuikChange Primer Design software (www.
genomics.agilent.com/primerDesignProgram.jsp). Mutagenesis was performed following the
manufacturer’s protocol. DNA from successful colonies was sent for sequencing (Source Bio-
science, UK) and positive clones were stored at -20°C.
Western blot
Protein samples from NRC and ARC cultures were prepared by scraping cells from the dish
using a cell scraper and by subsequent lysis in a protein loading buffer at 90°C for 10 minutes.
Protein samples were separated by SDS-PAGE using pre-cast NuPage 4–12% Bis Tris gels
(Invitrogen) and blotted onto PVDF membrane (Milipore). After the transfer, membranes
were blocked in TBST buffer supplemented with 5% milk (Sigma-Aldrich) for 1 hour at room
temperature, followed by overnight incubation with primary antibody at 4°C. The following
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antibodies diluted in TBST + 5% milk were used: polyclonal rabbit anti-Ms1 (aABD2chn,
1:25000) polyclonal rabbit anti-actin (Sigma-Aldrich, 1:200), polyclonal rabbit anti-lamin A
(Sigma-Aldrich, 1:200). After that, membranes were washed 3 times in TBST + 5% milk and
HRP-conjugated anti-rabbit or anti-mouse Igs secondary antibody was added (1:5000 dilution,
Santa Cruz). The secondary antibody was incubated for 1 hour at room temperature, followed
by 3 washes in TBST buffer. To detect the antibody, chemiluminescent reagent (Invitrogen)
was added and the blots were exposed to X-ray film (Fuji Film, RX NIF).
Cells
For the antibody validation, Hela cells were used (kindly provided by Dr. Stephen Terry). To
study Ms1 cellular localisation as well as for antibody validation, NRC (Neonatal Rat Cardio-
myocyte) and ARC (Adult Rat Cardiomyocyte) primary cell cultures were used. NRCs and
ARCs were produced from Sprague-Dawley rats as described previously [25,26]. Rats were
aged 1–2 days for NRCs and 6 months for ARCs.
Cell Transfection
Hela cells as described in [27] were plated on 12 mm glass cover slips in 6-well plate format.
They were transfected with myc-tagged Ms1 construct using Lipofectamine 2000 (Invitrogen).
For each well with a cover slip a mixture of 1μg of plasmid plus 5 μl of Lipofectamine in
DMEMmedium was added. Cells were incubated overnight, and the next day the medium was
changed into fresh DMEMmedium with 10% FCS. The transient transfection was carried out
for the next 48 hours. After that, cells were fixed with 4% paraformaldehyde (Agar Scientific)
in PBS for 10 min. for immunofluorescence or lysed for Western blot analysis.
NRCs as described in [28] were plated onto collagen-coated 35 mm culture dishes (PureCol;
Inamed Biomaterials). Transfection was done as for the Hela cells, except that Escort III
(Sigma-Aldrich) and different media depending on the experiment were used. To study cells in
the presence of a hypertrophic stimulus, the next day, the plating medium (68% DME, 16%
mediumM199, 10% horse serum, 5% fetal calf serum, 4 mM glutamine) was changed to main-
tenance medium (78% DME, 20% mediumM199, 4% horse serum, 1% penicillin–streptomy-
cin, 4 mM glutamine, and 0.1 mM phenylephrine [Sigma-Aldrich]). To study cells in the
absence of a hypertrophic stimulus, plating medium was used for the whole experiment. After
48 hours cells were fixed with 4% PFA in PBS for immunofluorescence or lysed for Western
blot analysis.
Cellular fractionation
Cellular fractionation was performed using the Subcellular Protein Fractionation kit for Cul-
tured Cells (Thermo Scientific) following the manufacturer’s protocol. Cellular fractionation
was performed for Hela, NRC and ARC cells yielding cytoplasmic, membrane, soluble nuclear,
chromatin-bound and cytoskeletal protein fractions. Later on each fraction was analysed for
the presence of Ms1 protein using Western blot.
Immunofluorescence
The following cell types were used for immunofluorescence: Hela, NRCs and ARCs. The
immunofluorescence protocol used was the same for all of them except that Hela cells were
plated on glass coverslips and NRCs and ARCs onto collagen-coated 35 mm culture dishes.
Briefly, cells were fixed for 10 minutes with 4% paraformaldehyde in PBS and permeabilised
for 5 minutes with 0.1% TX-100 in PBS, following by 1 wash in PBS. After that, they were
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blocked in the blocking reagent (Hela in 1%BSA in PBS, NRCs and ARCs in MAXblock, Activ
Motif) for 1 hour at room temperature. Later, the cells were incubated in the primary antibody
solution for 1 hour at room temperature (ARCs were incubated overnight at 4°C), followed by
3 washes in PBS and incubation in secondary antibody solution for 1 hour at room at room
temperature (or 5 hours at room temperature for ARCs). Primary and secondary antibodies
were diluted in 1% BSA in PBS. The following primary antibodies were used: polyclonal rabbit
anti-Ms1 (aABD2chn, 1:2000), monoclonal mouse anti-sarcomeric alpha-actinin, clone EA-
53 (Sigma-Aldrich, 1:500), monoclonal mouse anti-c-myc (Roche, 1:500). Polyclonal rabbit
anti-titin (M8 epitope) was kindly donated by Mathias Gautel (King’s College London, UK).
Primary antibodies were visualised using Alexa488-conjugated anti-mouse Igs and Cy-5-con-
jugated anti-rabbit Igs (Jackson ImmunoResearch Laboratories, Inc.) To visualise actin Alexa-
Fluor488- or AlexaFluor568-conjugated phalloidin was used (Invitrogen). For the nucleus
staining DAPI (Sigma-Aldrich) was used. Cells were mounted in 0.1 M Tris-HCl/glycerol (3:7)
and 50 mg/ml N-propylgallate, pH 9.5 and photographed using a Nikon microscope at 60x
magnification and a nominal aperture of 1.4 (Ar1 confocal). Images were processed using Ima-
geJ software.
Results
Structure of ABD2
The C-terminal domain of Ms1, which has a high sequence similarity to the small, homologous
protein COSTARS [9], was shown to be the only part of full length Ms1 to be folded on its own
[10]. It folds into a compact monomer as shown by size exclusion chromatography [10]. Analy-
sis of R1/R2 ratios [29] from 15N relaxation experiments for all rigid amino acids results in a τc
value of 7.4 +- 0.3 ns which is in good agreement with the value expected for a spherical protein
of 10 kD and its hydration shell. The structure was determined using standard NMRmethods
and has been submitted to the PDB, accession code 2KRH.
The structure is shown in Fig 1. The family of structures shows good agreement for all sec-
ondary structure elements and most loops. Some higher divergence is seen for the N-terminus
until the start of the first helix and loop 2. These regions of increased divergence show higher
levels of local mobility in 15N relaxation experiments (S2 Fig). The overall secondary structure
is comprised of three α-helices and a three stranded β-sheet making for a small and compact
overall shape.
The structure of Ms1/STARS ABD2 is globally very similar to that of its small homologue
COSTARS [9,12]. A DaliLite comparison gives a Cα RMSD of 3.0 Å and a Z-score of 8.3
despite a low sequence identity of only 34%. The only significant difference in the structures is
found in the loop between helix 1 and strand 1 where COSTARS has an additional short β-
strand whereas ABD2 has a short α-helix (see arrow in Fig 1C).
No proteins outside the Ms1 family with significant sequence similarity could be identified
by sequence searches. As a result, structural similarity searches with DALI [20] were performed
to gain more insight into the function of ABD2. Despite the initial identification of ABD2 as an
actin binding domain [10] no actin binding domain was identified in the top hits produced
by Dali (S3 Fig). Instead, the structure has a substantial similarity to winged helix-turn-helix
domains, a subset of the helix-turn-helix DNA binding domain family (Fig 1D). The basic
helix-turn-helix domain is a three helix core, which binds to DNA with its third helix [30,31].
The major distinguishing feature of a winged helix-turn-helix protein is the presence of a C-
terminal β-strand hairpin unit (the wing in the name of the protein domain family) [32,33].
This wing sometimes packs into the shallow cleft in the open core of the domain [34]; however,
this packing is absent in ABD2.
Ms1 Binds DNA and Can Act in the Nucleus
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In a typical domain containing a winged helix-turn-helix motif, the N-terminus contains
three α-helices (H1, H2 and H3) and three β-strands (S1, S2, and S3). In ABD2 these are
found at the following residues, H1 = R302 to M314, H2 = F325 to S338, H3 = V341 to H351.
Between H2 and H3 there is a short loop. The first β-strand is located between H1 and H2 (in
ABD2 this is I323 to F327), while the remaining β-strands are found after the third helix (in
ABD2 S2 = V354 to E357 and an irregular third strand S3 = V370 to L372). S2 and S3 are sepa-
rated by a loop, which forms the wing. The three strands form an anti-parallel β-sheet. In some
winged helix-turn-helix domains a second wing is found after the third β-strand, but this is not
present in ABD2. This is not because of any artificially chosen domain boundaries, but is
instead due to the full length Ms1 protein ending at residue 375. A second, C-terminal, wing is
also missing in other, otherwise typical, winged helix-turn-helix domains such as in histone H5
and E2F4 [35].
DNA binding
Initial DNA binding experiments using electrophoretic mobility shift assays (EMSA) with
ABD2 only gave a smear at very high protein concentrations but no clear shifted band, as in
the case of the positive control, using a random DNA library in good agreement with results
reported for COSTARS [12] (Fig 2A). However, it is not uncommon that monomeric, winged
Fig 1. Structure determination of rat ABD2. A: Stereo view of the family of the best 20 structures superimposed on the lowest energy structure. B:
Secondary structure of the lowest energy structure in the same orientation as in A. Key structural features are labeled, helices are coloured red and strands
are coloured yellow. C: Structural superposition of Ms1 ABD2 (red, PDB ID 2KRH) and COSTARS (blue, PDB ID 2L2O). Shown in the same orientation as in
B as well as rotated about 90° around the horizontal axis to reveal the structural differences in the segment connecting α1 and β1 (arrow). D: Structural
superposition of Ms1 ABD2 (red) on the three top hits of the DALI search in the PDB (1HR3 (green), 1SAX (blue), 1SD4 (yellow); for a list of the top 50 DALI
hits see S3 Fig).
doi:10.1371/journal.pone.0144614.g001
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helix loop helix domains are unable to bind to DNA on their own. Instead, it is well docu-
mented that they require an additional DNA binding motif, often referred to as “wing 2”
[36,37], to bind to DNA. We analysed the sequence N-terminal of the beginning of ABD2 at
residue 294 to see if there were any putative DNA binding motifs present that could act as
a second wing. We found a well defined AT-hook motif [38] starting from residue 279 in rea-
sonably good agreement with the consensus motif (Fig 2B) which is well conserved in Ms1
throughout evolution from invertebrates to mammals. Three N-terminally extended constructs
of ABD2 were generated starting from residues 270, 281 and 287 and used in another round of
EMSA experiments (Fig 2C). Strong shifts comparable to the positive control in Fig 2A are
seen for constructs starting at residue 281 and 270. The construct starting at residue 287 does
not contain the AT-hook and consequently behaves similarly to ABD2. To test if indeed the
predicted AT-hook is present and active in DNA binding we tested binding of Ms1 270–375
against double stranded oligonucleotides containing the sequence 5’-CGAATTAATTCG-3’
Fig 2. DNA binding of Ms1. A: EMSA experiment of ABD2 and FOXO3a as a positive control with a random 18mer library (2 μM). B: consensus motif of the
AT-hook shown as web logo [40] (based on PROSITE entry PDOC00306) and in short form on top of a sequence alignment of the AT-hook motif in selected
Ms1 sequences. Colours are: purple—hydrophilic; green—hydrophobic; orange—proline and glycine; blue—positive charge. Phosphorylation sites identified
experimentally are indicated by a star [15,41]. C: EMSA of N-terminally extended ABD2 constructs with the same 18mer random library used in A. The overall
Ms1 topology is shown together with the detail of the N-terminus of the various constructs. Residues at the N-terminus of ABD2 are shown in blue and those
of the AT-hook in red. D: NMR analysis of the interaction of Ms1 270–375 with AT-rich DNA ds oligonucleotides. Spectra of Ms1 270–375 without (black) and
with (1:0.5 red; 1:1 blue; 1:2 green) of the oligonucleotide are shown superimposed together with a detailed view for two selected residues from the N-
terminus. The chemical shift perturbations are summarised in a plot against the amino acid sequence that is annotated with the functional and structural
properties of the 270–375 construct.
doi:10.1371/journal.pone.0144614.g002
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which is typical for AT-hooks and which was previously shown to bind to the AT-hook of
HMGA1 [39]. Significant chemical shift perturbations are indeed observed for the AT-
hook alone while the rest of the construct does not show significant changes in the spectrum
(Fig 2D).
DNA binding specificity
After the identification of the Ms1 construct most suitable to bind to DNA double strands we
performed a SELEX experiment to test for sequence specificity. This involved a random library
with a random element of 18 bp extended by constant segments for cloning and annealing of
PCR primers (Gene Link). Protein to DNA ratio was set such that in the initial round no
shifted band was visible in normally stained agarose gels. The SELEX procedure was repeated
for 8 cycles whereupon a precise band became clearly visible (Fig 3A). The PCR product after
cycle 8 was cloned into pCR 2.1 vector using a TA cloning kit (Invitrogen). A total of 100 posi-
tive clones were sequenced and 42 interpretable sequences were obtained (shown in Fig 3B). A
good agreement is seen for the conserved sequence of (C/A/G)-AAA-(C/G) shown as web
logo [40] in Fig 3C. Synthetic oligonucleotides were synthesised incorporating this motif into
the sequence 5’-GACACAAACACAATAG-3’, which also contained an explicit AT rich
sequence flanking the conserved motif (wt and +AT oligos) because no clear sequence pattern
for an AT-hook binding site could be seen. Fluorescence titrations were performed using the
tryptophan residue in the wing of ABD2. Good, saturable binding is observed with an affinity
of 4.9 +- 0.7 μM (Fig 4A) for the extended +AT oligo and with an affinity of 8.2 ± 1 μM to the
wt oligo. To test the specificity of the core motif, a similar oligonucleotide was used in which
the central A of the conserved motif was replaced by a G (A7G oligo). Binding of this mutant
was much reduced to an affinity of 32 +- 5 μM and saturation of binding was much less appar-
ent, similar to an oligo that had the sequence of the wt olio mixed (scramble) and bound with
an affinity of 31 ± 4 μM.
To ensure that the conserved motif was indeed recognised by helix 3 in ABD2 the interac-
tion of both oligonucleotides with the protein was probed by NMR spectroscopy. It can be
seen in Fig 4B–4D that the AT-hook region, the linker that connects it with ABD2, helix 1
and helix 3 show significant chemical shift perturbations with the wt oligo. In contrast, using
the A7G oligo the magnitude of the perturbations is globally reduced, reflecting the reduced
binding affinity (Fig 4B and 4C). More importantly, a marked dent in the perturbation profile
is seen for helix 3 suggesting that indeed helix 3, the recognition helix, does contact the con-
served motif in the wt oligo. Mapping the most significant chemical shift perturbations on
the structure of ABD2 shows that only the regions facing the DNA respond to binding of the
oligonucleotide with the exception of helix 1 and parts of the N-terminus which are further
away (Fig 4D).
Subcellular localisation of Ms1
In previous reports Ms1 was mainly described as a cytosolic protein found attached to stress
fibres in non-muscle cells or to thin filaments in the sarcomeres of muscle cells [3]. Occasion-
ally Ms1 was sighted in the nucleus, even though the data were not shown [3] or the observa-
tion was not followed up [8]. To avoid confusion of development stages and cell/tissue types
we decided to focus on cardiomyocytes, in which the protein was first described, and to only
use primary cultures. In that way we could be sure that the cells were fully differentiated con-
taining all potential partner proteins that Ms1 might require to fully function. We used adult
rat cardiomyocytes (ARC) as representative of adult tissue and neonatal rat cardiomyocytes
(NRC) as a model for development and the stress response in adult tissue.
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Using a new antibody generated against ABD2 (aABD2chn, S4 and S5 Figs) we were able to
detect endogenous Ms1 easily in both NRCs and ARCs using both immunofluorescence and
western blots of subcellular fractions. As shown in Fig 5A in NRCs Ms1 is found exclusively in
the nucleus where it is stained in a punctate pattern reminiscent of PML bodies [42]. In con-
trast, in ARCs Ms1 is found exclusively in the sarcomere and the cytosol (Fig 5B). A broadly
similar picture emerges from western blots of subcellular fractions of NRCs and ARCs in Fig
5C: In NRCs all of the endogenous Ms1 is found in the nuclear fractions, the majority of which
is in the chromatin bound pool. In contrast, endogenous Ms1 in ARCs is found essentially only
in the cytosol.
To investigate the potential mechanism of nuclear translocation we searched for a nuclear
localisation signal (NLS) which we found using PredictNLS [16] starting at residue R153
(RRRKCTNLVSKLTKGWKVMEQEEPKWKS) in rat Ms1. The sequence alignment in Fig 5D
shows that this NLS is highly conserved in all vertebrate Ms1 sequences that also contain the
AT-hook. As a further confirmation of the detection of Ms1 we overexpressed myc-tagged wild
type mouse Ms1 in NRCs. Interestingly, overexpressed Ms1 was found in the nucleus only in
hypertrophic medium (Fig 6A) while it was in the cytosol in non hypertrophic medium. (Fig
6B). In contrast, endogenous Ms1 was found in the nucleus of NRCs regardless of the type of
medium (Fig 6A: non hypertrophic medium & Fig 6B: hypertrophic medium).
Fig 3. The specificity of DNA binding. A: Gel shift assays with DNA pools from stages 1 (first) and 8 (last) of the SELEX procedure with Ms1 270–375.
Positions of free and bound DNA are indicated. B: Sequencing results from the final SELEX pool after stage 8. Only random region shown, constant region is
omitted. C: Web logo [40] plot of the consensus DNA recognition motif of ABD2.
doi:10.1371/journal.pone.0144614.g003
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To establish if the nuclear translocation was dependent on the NLS shown in Fig 5D we
mutated two of the four positively charged residues in the core of the NLS of Ms1 to alanine
(RR->AA). Overexpression of this mutant, even in the presence of phenylephrine, abolished
nuclear translocation (Fig 6E).
Discussion
The structure determination of the only folded domain in the cardiac stress response factor
Ms1 gave the unexpected result of looking more like the DNA binding domain of a transcrip-
tion factor than an actin binding protein. A very similar result was obtained for the smaller
version of Ms1, COSTARS [12] even though this protein neither bound DNA nor actin. The
structures are overall very similar even though some significant local structural differences
were observed, most notable in the portion between helix 1 and strand 1 where COSTARS con-
tains a short extra strand whereas Ms1 ABD2 has a short helix (Fig 1C). Inspection of the raw
NMR data suggests that these divergent structures are indeed genuine and not artefacts,
Fig 4. Details of DNA recognition by Ms1. A: Fluorescence titrations of Ms1 270–375 with a double strand oligonucleotide representing the motif identified
in the SELEX procedure (wt), a version in which the central A of the motif is replaced by a G (A7G), the scrambled version of wt (scrambled) and a version
with additional AT base pairs (AT). Data points are shown in black, the fitting result in red. B: A full view and selected parts of 15N-1H HSQC spectra of Ms1
270–375 without (black), with the addition of the wt oligo (red) and the A7Gmutant oligo (blue) at a 2:1 ratio. Zoomed views are shown for two residues from
helix 3. C: plot of chemical shift perturbations of NMR interaction experiments of Ms1 270–375 with the wt (red) and A7G oligo (blue) against the protein
sequence. The dotted horizontal line represents the 1*σ noise level. Amino acids for which assignments are missing are labelled with black stars, those that
disappear in the titration are labelled with green stars. D: mapping of residues with significant chemical shift perturbations on the surface of the structure of
ABD2 (red: chemical sift perturbatios > 1*σ, orange: residues that disappear in the titration, grey: reidues for which assignments are missing). For residues
294–375 our experimental ABD2 structure is used to which residues 270–294 were added based on a homology model manually created using the known
structure of an AT-hook (PDB ID 2EZD).
doi:10.1371/journal.pone.0144614.g004
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possibly reflecting the rather distinct sequences of both proteins in this part of the structure
(the highly positively charged sequence ARHRR in Ms1 compared to GSKNA in COSTARS).
In agreement with data reported for COSTARS, Ms1 ABD2 did not bind clearly to DNA on
its own. However, analysis of the immediately preceding sequence of Ms1 revealed the presence
of an AT-hook, which was validated experimentally using NMR spectroscopy. A closer inspec-
tion of the AT-hook sequence in Ms1 shows that while the core GRP motif is well conserved
throughout (Fig 2B), several basic flanking amino acids are replaced by neutral or even nega-
tively charged amino acids. Such a variation of this motif would be expected to significantly
weaken the binding affinity of the AT-hook compared to more ideal versions. It is assumed
that this could serve the purpose of ensuring that significant DNA binding occurs only in coop-
eration of both motifs, the AT-hook and ABD2. A weakly binding AT-hook could also aid
scanning of DNA by one dimensional diffusion until a specific site is encountered [43,44]. Ms1
Constructs containing both AT-hook and ABD2 produced shifts in EMSA experiments com-
parable to the positive control FOXO3a (Fig 2A and 2C). Little effect is seen at a DNA:protein
ratio of 1:1 while almost all DNA is in a complex at 1:10 and 1:20. Such a behaviour is in good
agreement with the assumption of a KD value on the order of magnitude of tens of μM (compa-
rable to unspecific binding of Ms1 to the scramble or A7G oligonucleotides) so that less than
Fig 5. Subcellular localisation of Ms1. A: Immunofluorescent detection of endogenous Ms1 in NRCs. Staining is (left-to-right) DAPI (nuclei, blue), α-actinin
(green) and Ms1 (red). B: as A but in ARCs. C: western blot detection of Ms1 in subcellular fractions isolated from ARC and NRC cultures. C = cytoplasm,
M = membrane, SN = soluble nuclear, CH = chromatin bound, CS = cytoskeleton. D: Sequence alignment of Ms1 in the region of the nuclear localisation
signal (NLS). Phosphorylation sites identified experimentally are indicated by a star [41]. Colours and the subset of sequences are identical to those in Fig
2B. Note that Ms1 from lower organisms lack this region of the protein.
doi:10.1371/journal.pone.0144614.g005
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5% of complex would be formed at a ratio of 1:1 but more than 70% at a ratio of 1:10 and more
than 85% at a ratio of 1:20.
The SELEX experiment produced a well defined DNAmotif that was validated using syn-
thetic oligonucleotides. Fluorescence titrations showed a low micro molar binding affinity for
the wild type sequence. While numerous transcription factors bind to their recognition sites
with nanomolar affinities [45,46] others do bind with affinities comparable to that of ABD2,
e.g. AsH2L with a KD of about 4 μM [47] or various CXXC domains with KD values from 0.6 to
22 μM [48]. A single nucleotide mutation in the centre of the motif reduced the binding affinity
several fold as did an oligonucleotide with a scrambled sequence. Specific binding is also con-
firmed by NMR titration experiments that show significant chemical shift perturbations for the
AT-hook and recognition helix 3 which are almost completely abolished in titrations with the
A7G mutant oligonucleotide. Curiously, also the linker between the AT-hook and parts of
helix 1 show even larger chemical shift perturbations albeit no direct interaction with DNA is
expected in this part of the protein. However, as the N-terminus of Ms1 is opposite the DNA
Fig 6. Regulation of the subcellular localisation of Ms1. A: Overexpression of wt myc-tagged Ms1 in culture medium with phenylephrine; detection with
anti-myc antibody. B: Overexpression of wt Ms1 in NRCs in culture medium without phenylephrine; detection with anti-myc antibody. C: Detection of
endogenous Ms1 with aABD2chn in NRCs grown in culture medium without phenylephrine. D: Detection of endogenous Ms1 with aABD2chn in NRCs grown
in culture medium with phenylephrine. E: Overexpression of Ms1 with RR->AAmutation of NLS in NRCs grown in presence of phenylephrine; detection with
anti-myc antibody.
doi:10.1371/journal.pone.0144614.g006
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recognition helix it follows that the linker sequence has to run past the rest of the domain to
allow the AT-hook to approach the DNA. Consequently, the linker residues would come close
to the N-terminus of ABD2 and could even make stabilising contacts. This is supported by the
observation of increasing melting temperatures for the increased length of the N-terminally
extended constructs (S6 Fig). No changes in melting temperature would be expected in the
absence of interactions. Such interactions are also directly observed in comparisons of chemical
shift differences of shorter and longer constructs which show chemical shift perturbations in
helix 1 similar to those observed upon DNA binding (S6 Fig). This part of the protein will also
experience significant conformational changes upon DNA binding which explains the dispro-
portionately large chemical shift perturbations in comparison to the recognition helix where
they are more moderate. The latter suggests that the recognition helix does not change confor-
mation very much and that even the side chains need only small changes to fit into the major
groove of the DNAmolecule.
To act as a transcription factor a protein ought to be able to reach the nucleus. A standard
means to get there is a nuclear localisation signal (NLS), which does indeed exist in Ms1 fol-
lowing residue R153. Interestingly, though, so far most reports in the literature reported
essentially exclusively cytoplasmic localisation. Occasional sightings [3,8] were not followed
up to our knowledge. We found Ms1 in the nucleus so far only under what appears to be
tightly controlled conditions in primary cultures of neonatal rat cardiomyocytes (NRCs).
Both subcellular fractionation and immunofluorescence suggest that Ms1 fulfils a specific
function in the nucleus: by showing that it is tightly associated with the chromosomal material
(fractionation) and by its appearance in a speckled or spotted pattern in the nucleus (immu-
nofluorescence). Such patterns, e.g. PML bodies [42,49], are thought to correspond to
increased activity of DNA replication, splicing or transcription. It remains to be seen into
which of these categories of function Ms1 falls. Interestingly, while endogenous Ms1 was
always in the nucleus in NRCs, overexpressed Ms1 was only in the nucleus in hypertrophic
medium. This suggests a complex pattern of spatiotemporal regulation of Ms1 where an early
developmental signal is expected to drive Ms1 into the nucleus, which is already switched off
at birth. As a consequence, overexpressed Ms1 requires extra signals to get into the nucleus.
Due to a lack of a nuclear export signal (based on sequence analysis of rat Ms1 with NetNES
1.1 server [50]) nuclear export of Ms1 must be less efficient, in good agreement with our
observations. Therefore, it can be assumed that Ms1 is actively transported to the nucleus
early in cardiac development, a pattern that is expected to be repeated in the stress response of
adult cardiomyocytes. At the latest around birth this nuclear import is switched off but is not
accompanied by active export of Ms1. Nevertheless at some point in postnatal development
nuclear export must happen because in ARCs Ms1 is not in the nucleus anymore. Our data
suggest that nuclear import depends on the NLS as its mutation abolished it. Interestingly, it
has been shown experimentally that S156 (human numbering, S150 in mouse and rat, Fig 5D)
is phosphorylated by a p38 like kinase [15,41] which could regulate its activity [51,52]. Other
opportunities for regulation of Ms1 activity exist with regards to DNA binding where the con-
served Y286 in the AT-hook and S338 at the N-terminus of the recognition helix have been
shown experimentally to be phosphorylated [15,41].
In conclusion we have shown that Ms1 possesses all the necessary attributes to be directly
involved in control of transcription: it can bind to specific sites in DNA and can translocate to
the nucleus. While it is too early to make specific predictions as to its precise function in the
nucleus it might be fruitful to speculate as to what it might be. We would therefore like to sug-
gest that Ms1 in the nucleus is involved in the stimulation of the expression of genes needed for
the buildup of muscle mass as required both in early embryonal development as well as in the
hypertrophic response to stress situations in adults. Ms1 could do so most likely directly as a
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transcription factor or less likely indirectly via an involvement in mRNA processing. Such a
function is supported by the assumption that its nuclear translocation is driven by upstream
signals acting via a p38-like kinase which in turn would be activated by hypertrophic signalling.
Having a well defined postulated function will facilitate further experimental exploration of
this unexpectedly versatile stress response protein.
Supporting Information
S1 Fig. Alignment of a selection of full length Ms1 protein sequences. A selection of func-
tional features, structural domains and secondary structure elements are shown by bars. Exper-
imentally identified phosphorylation sites that are conserved amongst mammals are indicated
by red stars.
(PDF)
S2 Fig. Backbone dynamics analysis of ABD2. On the left are shown the experimental values
for 15N T1, T2 and heteronuclear NOE recorded at 500 MHz. On the right are two parameters
from the Lipari-Szabo analysis, the order parameter S2 and the exchange contribution Rex.
Apart from a small region in the wing there is little flexibility in the compact structure.
(PDF)
S3 Fig. Top 50 hits of DALI search of the PDB with the structure of ABD2. Proteins that are
not involved in DNA binding are marked with a blue star. Structures used in the superposition
in Fig 1D are marked with red stars.
(PDF)
S4 Fig. Western blot validation of new antibody against Ms1. The antibody (aABD2chn)
was generated for detection of endogenous Ms1. It was validated by western blots with myc-
tagged full length Ms1 expressed in COS cells (left); western blots of endogenous Ms1 in muscle
tissue extracts with untreated and blocked antibody (lower left); western blots of overexpressed
myc-tagged full length Ms1 in HeLa cells (below);
(PDF)
S5 Fig. Immunofluorescence validation of new antibody Ms1. Immunofluorescence detec-
tion of transfected full length myc-tagged Ms1 in HeLa cells using anti-myc as well as
aABD2chn antibodies (left) and immunofluorescence detection of endogenous Ms1 in NRCs
with untreated and blocked aABD2chn (right).
(PDF)
S6 Fig. Effects of potential interactions of the N-terminal extension of ABD2 on stability
and NMR spectra of ABD2. A significant increase in stability of> 7°C is seen for the addition
of 23 amino acids at the N-terminus of ABD2.This addition leads to considerable chemical
shift changes around helix one to which it would need to pack to allow the AT-hook to reach
the DNA.
(PDF)
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